Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2011
04/06/2011CN102000121A Cordyceps militaris oligopeptide composition as well as preparation method and use thereof
04/06/2011CN102000022A Recombined bifunctional plasmin freeze-drying preparation for injection and preparation method thereof
04/06/2011CN101612114B Recombinant human interferon a2b suppository and preparation method thereof
04/06/2011CN101497652B Peptide for inhibiting solid tumor and leukaemia cancer cell growth and use thereof
04/06/2011CN101475936B EDRF gene fragment
04/06/2011CN101457207B Eosinophil beta-mannanase MAN5A and gene and application thereof
04/06/2011CN101417122B Recombination chicken alpha-interferon injection and preparation method thereof
04/06/2011CN101412995B Polyethyleneglycol modified aprotinin and preparation thereof
04/06/2011CN101337065B Use of MG132 in preparing medicine for synergistic inductive differentiation therapy of leukaemia
04/06/2011CN101314032B Preparation technique for specified transfer factor oral preparation for typhoid fever, paratyphoid fever
04/06/2011CN101302252B Extrasin alphal (Tal) analogue, production process and medical use thereof
04/06/2011CN101270151B Peptide medicaments for accelerating medulla hematopoiesis cell proliferation
04/06/2011CN101214375B Improved vaccines
04/06/2011CN101147779B Composition containing nucleotide, its preparation method and its use
04/06/2011CN101035805B Deglycosylated and desialidated long pentraxin PTX3
04/05/2011USRE42274 Cyclic peptide CXCR4 antagonists
04/05/2011US7919612 Comprises modified nucleotide sequences for use in gene expression inhibition, viral defense, transposon silencing and treatment of metabolic disorders; antisense agents
04/05/2011US7919609 Toxins
04/05/2011US7919606 Biological products
04/05/2011US7919604 Fetal genes
04/05/2011US7919592 Using microfiltration to remove microorganism from solution ccomprised of fibrinogen and/or antihemophilic factor
04/05/2011US7919591 Modified human plasma polypeptide or Fc scaffolds and their uses
04/05/2011US7919582 Neuregulin-β isoform
04/05/2011US7919581 Bi-dentate compounds as kinase inhibitors
04/05/2011US7919578 Methods and compositions for inhibition of BCL6 repression
04/05/2011US7919577 Peptide analog with substitutions useful for therapy and prophylaxis of diseases and disorders related to ACTH, ACTH receptors or corticosteroid secretion, such as premature labor and Cushing's Disease; veterinary medicine, agriculture, aquaculture
04/05/2011US7919478 Using vascular endothelial growth factor as wound healing agent; tissue engineering; regenerative medicine; wound healing agent
04/05/2011US7919474 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening
04/05/2011US7919471 Method of modulating cell survival and reagents useful for same
04/05/2011US7919470 Glycopeptide composition with improved antibiotic activity
04/05/2011US7919469 Methods and compositions for altering mucus secretion
04/05/2011US7919468 Compounds useful as modulators of the proteasome activity
04/05/2011US7919467 Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer
04/05/2011US7919466 Lymphatic zip codes in tumors and pre-malignant lesions
04/05/2011US7919465 Peptide mimotopes that inhibits interaction between a platelet receptor and a platelet receptor ligand
04/05/2011US7919464 Use of a peptide that interacts with αvβ3 integrin of endothelial cell
04/05/2011US7919463 Growth-stimulating polypeptides for use in fish and crustaceans
04/05/2011US7919462 Inhibitors of human plasmin derived from the Kunitz domains
04/05/2011US7919461 Utilizing amino acid sequences linked to polyethylene glycol as agonists; increasing red blood cell production; chronic kidney disease
04/05/2011US7919460 administering a prophylactically effective amount of natural calcitonin or a calcitonin derivative (elcatonin) to a stroke patient
04/05/2011US7919459 Cardiovascular disorders; antidiabetic agents; respiratory system disorders; antagonist of protein g receptor
04/05/2011US7919458 Method of inhibiting prostate cancer cell proliferation
04/05/2011US7919456 Connective tissue derived polypeptides
04/05/2011US7919455 Marked peptides having affinity for a phospholipid and uses
04/05/2011US7919454 Methods of treating using conjugates transported by a PEPT2 transporter
04/05/2011US7919329 Method for screening for agents that affect food intake
04/05/2011US7919309 Method for expression of small antiviral RNA molecules within a cell
04/05/2011US7919274 Detecting position of particle in cell; obtain cell, administer with light emitting fusion protein, detect signal, image signal
04/05/2011US7919269 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
04/05/2011US7919118 Spacer moiety for poly (ethylene glycol) modified peptide based compounds
04/05/2011US7919104 Functional epitopes of Streptococcus pneumoniae PsaA antigen and uses thereof
04/05/2011US7919103 Compound and method for regulating plasminogen activation and cell migration
04/05/2011US7919099 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides
04/05/2011US7919098 ErbB-3 based methods and compositions for treating neoplasms
04/05/2011US7919097 using a composition comprising a multimeric galectin-1 polypeptide; inflammatory bowel disease, food allergies or asthma; Crohn's disease or ulcerative colitis; multiple sclerosis, diabetes, rheumatoid arthritis, or systemic lupus erythematosis
04/05/2011US7919091 Lipolysis stimulated receptor (LSR) specific antibodies
04/05/2011US7919085 Using secretory carrier membrane protein 5 protein specific monoclonal antibody as diagnostic tool in screening for cutaneous t-cell lymphomas (CTCL)
04/05/2011US7919082 High-activity mutants of butyrylcholinesterase for cocaine hydrolysis and method of generating the same
04/05/2011US7919078 Modified cytokine for use in treatment and prevention of viral infection, cell proliferative and autoimmune diseases
04/05/2011US7919077 Pharmaceutical compositions comprising CCL2 and use of same for the treatment of inflammation
04/05/2011CA2466170C Hexa-, hepta-, and octapeptides having antiangiogenic activity
04/05/2011CA2461703C Modulation of physiological processes and agents useful for same
04/05/2011CA2447909C Use of proteasome inhibitors to treat dry eye disorders
04/05/2011CA2437788C Inflammation-inhibiting compounds
04/05/2011CA2429027C Antibodies against human receptor h4-1bb
04/05/2011CA2379776C A device for spray dispensing a composition for topical application comprising vitamin e and essential fatty acids
04/05/2011CA2346119C A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5
04/05/2011CA2309355C Tissue cement proteins from rhipicephalus appendiculatus
04/05/2011CA2284547C Mu-opiate receptor peptides
04/05/2011CA2261562C Fusion polypeptides comprising an ige-binding domain and a hsa component, and their diagnostic and therapeutic uses
04/05/2011CA2229163C Methods for enhancing the production of viral vaccines in cell culture by interferon suppression
04/02/2011CA2715959A1 Surgical compositions
04/01/2011CA2697568A1 Cancer therapy
03/2011
03/31/2011WO2011038417A2 Methods to accelerate tissue and wound healing rates and reduce swelling and scar formation
03/31/2011WO2011038293A1 Cyclic peptide inhibitors of hepatitis c virus replication
03/31/2011WO2011038283A1 Novel macrocyclic inhibitors of hepatitis c virus replication
03/31/2011WO2011038259A1 Synthetic glycosyl hydrolase based on dna nanoweaves
03/31/2011WO2011038149A2 Methods of treating inflammation
03/31/2011WO2011038142A2 Bladder cancer specific ligand peptides
03/31/2011WO2011038139A1 Treatment of ovarian cancer using a specific binding agent of human angiopoietin-2 in combination with a taxane
03/31/2011WO2011038122A1 Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same
03/31/2011WO2011038054A1 COMPOSITIONS AND METHODS FOR INHIBITING Gα PROTEIN SIGNALING
03/31/2011WO2011038049A1 Peptidomimetic macrocycles
03/31/2011WO2011038015A1 Method of treating osteoporosis with a neurotoxin
03/31/2011WO2011038014A2 Composition and method for treatment of diabetes
03/31/2011WO2011038004A1 Methods and compositions for in-vivo enzyme capture
03/31/2011WO2011038002A1 Immunogenic epitopes as targets for universal cancer vaccines
03/31/2011WO2011037970A1 Podocyte ph modulation and uses thereof
03/31/2011WO2011037859A2 Identification of antigenic peptides from multiple myeloma cells
03/31/2011WO2011037760A2 Composite layered hemostasis device
03/31/2011WO2011037483A1 Method for accelerating the development of mammalian livestock
03/31/2011WO2011037157A1 Eye drops
03/31/2011WO2011037058A1 Lactase preparation
03/31/2011WO2011036665A2 Akt/mtorc1 pathway activators for use in increasing liver regeneration
03/31/2011WO2011036487A1 Cancer therapy
03/31/2011WO2011036444A1 Heparin cofactor ii fragments with anti-inflammatory and anti-coagulant activity
03/31/2011WO2011036440A1 Antagonists of dsg2 for treatment of cancer
03/31/2011WO2011036297A2 Method for the therapy and diagnosis of alzheimer's disease
03/31/2011WO2011036174A1 A novel method for the production of a antimicrobial peptide
03/31/2011WO2011035829A1 Pharmaceutical compositions for treating dysregulated inflammatory diseases